Skip to main content
medichelpline
Back to Clinical Feed
Try:
Front ImmunolInfectious Disease

Synergistic TCR-independent action of IL-33 and IL-12 drive a potent IFNγ secretory program in human circulating MAIT cells with immunomodulatory properties

26 Jun 20264 min read0 viewsJournal Feed

GIST

IntroductionMucosal-Associated Invariant T (MAIT) cells are a subset of unconventional T cells that rapidly respond to early signs of inflammation, infection, and tissue damage. While MAIT cells have been typically associated with microbial infections, given their ability to respond to both microbial-derived riboflavin metabolites and proinflammatory cytokines such as IL-12, IL-15, or IL-18, their role in other inflammatory conditions remains mostly unknown.

Alarmins, including IL-25, IL-33, and thymic stromal lymphopoietin (TSLP), are crucial effectors for early inflammatory responses, being released upon epithelial damage and strongly promoting the polarization of a wide variety of immune cells, including leukocytes like neutrophils, monocytes, macrophages, dendritic cells (DCs), NK cells, ILCs and T cells. However, how alarmins-induced environments influence MAIT cells' activity and function is yet to be explored.

MethodsIn this study, we investigate the roles of alarmins in controlling MAIT cell activation and function. ResultsWe found that IL-33, but not IL-25 or TSLP, combined with the TCR-independent stimuli IL-12p70 (but not 5-OP-RU), induces a potent IFNγ secretory/cytotoxic program on MAIT cells.

This response was strongly dependent on p38 MAPK signaling and glycolytic metabolism.

Clinical Editorial

Summary

Frontiers in Immunology published a clinical update in Infectious Disease on 26 Jun 2026.

The item focuses on Synergistic TCR-independent action of IL-33 and IL-12 drive a potent IFNγ secretory program in human circulating MAIT cells with immunomodulatory properties.

Review the original article for the full source wording and details.

Source Reference

Read the full original publication from the source journal or publisher link below.